Temat: "Fetal Blood" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Allogeneic umbilical cord blood-derived mesenchymal stem cell implantation versus microdrilling combined with high tibial osteotomy for cartilage regeneration.
Autorzy:: Jung SH; Arthroscopy and Joint Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.; Department of Orthopedic Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul, 06273, Republic of Korea.
Nam BJ; Arthroscopy and Joint Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.; Department of Orthopedic Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul, 06273, Republic of Korea.
Choi CH; Arthroscopy and Joint Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.; Department of Orthopedic Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Kim S; Department of Radiology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Jung M; Arthroscopy and Joint Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.; Department of Orthopedic Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Chung K; Arthroscopy and Joint Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.; Department of Orthopedic Surgery, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea.
Park J; Arthroscopy and Joint Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.; Department of Orthopedic Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul, 06273, Republic of Korea.
Jung Y; Department of Orthopedic Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Kim SH; Arthroscopy and Joint Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea. .; Department of Orthopedic Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul, 06273, Republic of Korea. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 09; Vol. 14 (1), pp. 3333. Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:: Journal Article
MeSH Terms:: Cartilage, Articular*/surgery
Cartilage, Articular*/pathology
Osteoarthritis, Knee*/surgery
Osteoarthritis, Knee*/pathology
Mesenchymal Stem Cells*
Hematopoietic Stem Cell Transplantation*
Mesenchymal Stem Cell Transplantation*
Humans ; Fetal Blood ; Second-Look Surgery ; Osteotomy ; Regeneration

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Mesenchymal Stromal Cells from Perinatal Tissues as an Alternative for Ex Vivo Expansion of Hematopoietic Progenitor and Stem Cells from Umbilical Cord Blood.
Autorzy:: Bonilla X; Pharmaceutical Biotechnology Unit, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud, Bogotá 111611, Colombia.
Lara AM; Pharmaceutical Biotechnology Unit, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud, Bogotá 111611, Colombia.
Llano-León M; Advanced Therapies Unit, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud, Bogotá 111611, Colombia.
López-González DA; Pharmaceutical Biotechnology Unit, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud, Bogotá 111611, Colombia.
Hernández-Mejía DG; Advanced Therapies Unit, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud, Bogotá 111611, Colombia.
Bustos RH; Therapeutic Evidence Group, Clinical Pharmacology, Universidad de La Sabana and Clínica Universidad de La Sabana, Chía 140013, Colombia.
Camacho-Rodríguez B; Pharmaceutical Biotechnology Unit, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud, Bogotá 111611, Colombia.
Perdomo-Arciniegas AM; Cord Blood Bank, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud, Bogotá 111611, Colombia.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Oct 24; Vol. 24 (21). Date of Electronic Publication: 2023 Oct 24.
Typ publikacji:: Journal Article
MeSH Terms:: Mesenchymal Stem Cells*
Hematopoietic Stem Cell Transplantation*/methods
Hematologic Diseases*
Pregnancy ; Female ; Adult ; Humans ; Antigens, CD34 ; Fetal Blood ; Hematopoietic Stem Cells ; Coculture Techniques ; Cell Proliferation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Donor cord blood aging accelerates in recipients after transplantation.
Autorzy:: Onizuka M; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Kanagawa, 259-1143, Japan. .
Imanishi T; Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Kanagawa, 259-1143, Japan.
Harada K; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Kanagawa, 259-1143, Japan.
Aoyama Y; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Kanagawa, 259-1143, Japan.
Amaki J; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Kanagawa, 259-1143, Japan.
Toyosaki M; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Kanagawa, 259-1143, Japan.
Machida S; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Kanagawa, 259-1143, Japan.
Kikkawa E; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Kanagawa, 259-1143, Japan.
Yamada S; Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Kanagawa, 259-1143, Japan.
Nakabayashi K; Department of Maternal-Fetal Biology, Research Institute, National Center for Child Health and Development, Tokyo, 157-8535, Japan.
Hata K; Department of Maternal-Fetal Biology, Research Institute, National Center for Child Health and Development, Tokyo, 157-8535, Japan.; Department of Molecular and Cellular Biology, Gunma University Graduate School of Medicine, Gunma, 371-8511, Japan.
Higashimoto K; Division of Molecular Genetics and Epigenetics, Department of Biomolecular Sciences, Faculty of Medicine, Saga University, Saga, 849-8501, Japan.
Soejima H; Division of Molecular Genetics and Epigenetics, Department of Biomolecular Sciences, Faculty of Medicine, Saga University, Saga, 849-8501, Japan.
Ando K; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Kanagawa, 259-1143, Japan.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Feb 14; Vol. 13 (1), pp. 2603. Date of Electronic Publication: 2023 Feb 14.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hematopoietic Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/methods
Graft vs Host Disease*
Cord Blood Stem Cell Transplantation*/adverse effects
Humans ; Infant, Newborn ; Child ; Fetal Blood ; Transplantation, Homologous ; Blood Donors ; Cellular Senescence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: The clinical outcomes of mixed engraftment patients treated with haploidentical stem cells combined with umbilical cord blood transplantation.
Autorzy:: Liu Y; Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, PR China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, PR China.
Qi L; Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, PR China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, PR China.
Wang T; Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, PR China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, PR China.
Zhou B; Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, PR China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, PR China.
Chen J; Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, PR China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, PR China.
Xiao J; Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, PR China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, PR China.
Fang Y; Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, PR China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, PR China.
Yang Q; Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, PR China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, PR China.
Feng Y; Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, PR China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, PR China.
Wu D; Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, PR China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, PR China.
Xu Y; Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, PR China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, PR China.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2022 Nov; Vol. 63 (11), pp. 2696-2700. Date of Electronic Publication: 2022 Jun 18.
Typ publikacji:: Letter; Research Support, Non-U.S. Gov't
MeSH Terms:: Cord Blood Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/adverse effects
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Humans ; Transplantation Conditioning ; Fetal Blood

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Unrelated umbilical cord blood can improve the prognosis of haploidentical hematopoietic stem cell transplantation.
Autorzy:: Yang Y; Shengjing Hospital of China Medical University, Shenyang, China.
Zhang M; Shengjing Hospital of China Medical University, Shenyang, China.
Li M; Shengjing Hospital of China Medical University, Shenyang, China.
Li Y; Shengjing Hospital of China Medical University, Shenyang, China.
Yang W; Shengjing Hospital of China Medical University, Shenyang, China.
Liu Z; Shengjing Hospital of China Medical University, Shenyang, China.
Wang H; Shengjing Hospital of China Medical University, Shenyang, China. .; Pokaż więcej
Źródło:: Stem cell research & therapy [Stem Cell Res Ther] 2022 Sep 24; Vol. 13 (1), pp. 485. Date of Electronic Publication: 2022 Sep 24.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Cord Blood Stem Cell Transplantation*/methods
Graft vs Host Disease*/etiology
Graft vs Host Disease*/therapy
Hematopoietic Stem Cell Transplantation*/methods
Cohort Studies ; Fetal Blood ; Humans ; Retrospective Studies ; Transplantation Conditioning/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Role of flow cytometry in evaluation of the cellular therapy products used in haematopoietic stem cell transplantation.
Autorzy:: Rimac V; Clinical Department of Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Zagreb, Croatia.
Bojanić I; Clinical Department of Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Zagreb, Croatia.; Pokaż więcej
Źródło:: International journal of laboratory hematology [Int J Lab Hematol] 2022 Jun; Vol. 44 (3), pp. 446-453. Date of Electronic Publication: 2022 Apr 13.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Bone Marrow ; Fetal Blood ; Flow Cytometry/methods ; Hematopoietic Stem Cells ; Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Combination of SB431542, Chir9901, and Bpv as a novel supplement in the culture of umbilical cord blood hematopoietic stem cells.
Autorzy:: Zarrabi M; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, P.O. Box, Tehran, 19395-4644, Iran.; Royan Stem Cell Technology Company, Cord Blood Bank, Tehran, Iran.
Afzal E; Royan Stem Cell Technology Company, Cord Blood Bank, Tehran, Iran.
Asghari MH; Animal Core Facility, Reproductive Biomedicine Research Center, Royan Institute for Animal Biotechnology, ACECR, Tehran, Iran.
Ebrahimi M; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, P.O. Box, Tehran, 19395-4644, Iran. .; Pokaż więcej
Źródło:: Stem cell research & therapy [Stem Cell Res Ther] 2020 Nov 09; Vol. 11 (1), pp. 474. Date of Electronic Publication: 2020 Nov 09.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Fetal Blood*
Hematopoietic Stem Cell Transplantation*
Animals ; Antigens, CD34 ; Benzamides ; Cell Proliferation ; Cells, Cultured ; Dioxoles ; Glycogen Synthase Kinase 3 ; Hematopoietic Stem Cells ; Mice

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Co-administration of human MSC overexpressing HIF-1α increases human CD34 cell engraftment in vivo.
Autorzy:: Preciado S; Cell Therapy Unit, Hematology Department, University Hospital of Salamanca, IBSAL, University of Salamanca, Paseo de San Vicente 58-182, 37007, Salamanca, Spain.; RETIC TerCel, ISCIII, Madrid, Spain.; Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y León, Salamanca, Spain.
Sirerol-Piquer MS; Departamento de Biología Celular, Biología Funcional y Antropología Física, University of Valencia, Burjassot, Spain.; Instituto de Biotecnología y Biomedicina (BioTecMed), University of Valencia, Burjassot, Spain.; RETIC TerCel, ISCIII, Madrid, Spain.
Muntión S; Cell Therapy Unit, Hematology Department, University Hospital of Salamanca, IBSAL, University of Salamanca, Paseo de San Vicente 58-182, 37007, Salamanca, Spain.; RETIC TerCel, ISCIII, Madrid, Spain.; Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y León, Salamanca, Spain.
Osugui L; Cell Therapy Unit, Hematology Department, University Hospital of Salamanca, IBSAL, University of Salamanca, Paseo de San Vicente 58-182, 37007, Salamanca, Spain.; RETIC TerCel, ISCIII, Madrid, Spain.; Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y León, Salamanca, Spain.
Martí-Chillón GJ; Cell Therapy Unit, Hematology Department, University Hospital of Salamanca, IBSAL, University of Salamanca, Paseo de San Vicente 58-182, 37007, Salamanca, Spain.; RETIC TerCel, ISCIII, Madrid, Spain.; Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y León, Salamanca, Spain.
Navarro-Bailón A; Cell Therapy Unit, Hematology Department, University Hospital of Salamanca, IBSAL, University of Salamanca, Paseo de San Vicente 58-182, 37007, Salamanca, Spain.; RETIC TerCel, ISCIII, Madrid, Spain.; Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y León, Salamanca, Spain.
Sepúlveda P; Regenerative Medicine and Heart Transplantation Unit, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.; RETIC TerCel, ISCIII, Madrid, Spain.
Sánchez-Guijo F; Cell Therapy Unit, Hematology Department, University Hospital of Salamanca, IBSAL, University of Salamanca, Paseo de San Vicente 58-182, 37007, Salamanca, Spain. .; RETIC TerCel, ISCIII, Madrid, Spain. .; Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y León, Salamanca, Spain. .; Pokaż więcej
Źródło:: Stem cell research & therapy [Stem Cell Res Ther] 2021 Dec 07; Vol. 12 (1), pp. 601. Date of Electronic Publication: 2021 Dec 07.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Mesenchymal Stem Cells*/metabolism
Hypoxia-Inducible Factor 1, alpha Subunit/*metabolism
Animals ; Antigens, CD34/genetics ; Antigens, CD34/metabolism ; Fetal Blood ; Humans ; Hypoxia-Inducible Factor 1, alpha Subunit/genetics ; Mice ; Mice, Inbred NOD ; Mice, SCID

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Arterial endothelium creates a permissive niche for expansion of human cord blood hematopoietic stem and progenitor cells.
Autorzy:: Li H; Stem Cell and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine, Beijing, 100850, China.
Pei H; Experimental Hematology and Biochemistry Lab, Beijing Institute of Radiation Medicine, Beijing, 100850, China. .; South China Research Center for Stem Cell & Regenerative Medicine, SCIB, Guangzhou, 510005, China. .
Wang S; Stem Cell and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine, Beijing, 100850, China.; South China Research Center for Stem Cell & Regenerative Medicine, SCIB, Guangzhou, 510005, China.
Zhang B; Experimental Hematology and Biochemistry Lab, Beijing Institute of Radiation Medicine, Beijing, 100850, China.; South China Research Center for Stem Cell & Regenerative Medicine, SCIB, Guangzhou, 510005, China.
Fan Z; Stem Cell and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine, Beijing, 100850, China.
Liu Y; Stem Cell and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine, Beijing, 100850, China.; South China Research Center for Stem Cell & Regenerative Medicine, SCIB, Guangzhou, 510005, China.
Xie X; Stem Cell and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine, Beijing, 100850, China.; South China Research Center for Stem Cell & Regenerative Medicine, SCIB, Guangzhou, 510005, China.
Yang Z; Stem Cell and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine, Beijing, 100850, China.
Xu L; Stem Cell and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine, Beijing, 100850, China.
Jia Y; Experimental Hematology and Biochemistry Lab, Beijing Institute of Radiation Medicine, Beijing, 100850, China.; South China Research Center for Stem Cell & Regenerative Medicine, SCIB, Guangzhou, 510005, China.
Bai Y; Stem Cell and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine, Beijing, 100850, China.
Han Y; South China Research Center for Stem Cell & Regenerative Medicine, SCIB, Guangzhou, 510005, China.
Chen L; Stem Cell and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine, Beijing, 100850, China.; South China Research Center for Stem Cell & Regenerative Medicine, SCIB, Guangzhou, 510005, China.
He L; Stem Cell and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine, Beijing, 100850, China.; South China Research Center for Stem Cell & Regenerative Medicine, SCIB, Guangzhou, 510005, China.
Nan X; Stem Cell and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine, Beijing, 100850, China.; South China Research Center for Stem Cell & Regenerative Medicine, SCIB, Guangzhou, 510005, China.
Yue W; Stem Cell and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine, Beijing, 100850, China. .; South China Research Center for Stem Cell & Regenerative Medicine, SCIB, Guangzhou, 510005, China. .
Pei X; Stem Cell and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine, Beijing, 100850, China. .; South China Research Center for Stem Cell & Regenerative Medicine, SCIB, Guangzhou, 510005, China. .; Pokaż więcej
Źródło:: Stem cell research & therapy [Stem Cell Res Ther] 2020 Aug 14; Vol. 11 (1), pp. 358. Date of Electronic Publication: 2020 Aug 14.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Fetal Blood*
Hematopoietic Stem Cell Transplantation*
Antigens, CD34/genetics ; Cells, Cultured ; Coculture Techniques ; Endothelium ; Hematopoietic Stem Cells ; Humans

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34 -enriched cells.
Autorzy:: Bucar S; Department of Bioengineering and iBB - Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal.; Associate Laboratory i4HB - Institute for Health and Bioeconomy, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal.
Branco ADM; Department of Bioengineering and iBB - Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal.; Associate Laboratory i4HB - Institute for Health and Bioeconomy, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal.
Mata MF; Department of Bioengineering and iBB - Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal.
Milhano JC; Hospital São Francisco Xavier, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal.
Caramalho Í; Instituto Gulbenkian de Ciência, Oeiras, Portugal.
Cabral JMS; Department of Bioengineering and iBB - Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal.; Associate Laboratory i4HB - Institute for Health and Bioeconomy, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal.
Fernandes-Platzgummer A; Department of Bioengineering and iBB - Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal.; Associate Laboratory i4HB - Institute for Health and Bioeconomy, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal.
da Silva CL; Department of Bioengineering and iBB - Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal. claudia_.; Associate Laboratory i4HB - Institute for Health and Bioeconomy, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal. claudia_.; Pokaż więcej
Źródło:: Stem cell research & therapy [Stem Cell Res Ther] 2021 Jul 13; Vol. 12 (1), pp. 399. Date of Electronic Publication: 2021 Jul 13.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Mesenchymal Stem Cells*
Adult ; Antigens, CD34 ; Cells, Cultured ; Fetal Blood ; Hematopoietic Stem Cells ; Humans

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Comparison of Hematopoietic Stem Cell Transplantation Results in Patients with β-Thalassemia Major from Three Different Graft Types.
Autorzy:: Aydogdu S; Department of Pediatrics, Faculty of Medicine, Pediatric Bone Marrow Transplantation Unit, Bahcelievler Medical Park Hospital, Altinbas University, Istanbul, Turkey.
Toret E; Department of Pediatrics, Faculty of Medicine, Pediatric Bone Marrow Transplantation Unit, Bahcelievler Medical Park Hospital, Altinbas University, Istanbul, Turkey.
Aksoy BA; Department of Pediatrics, Faculty of Medicine, Pediatric Bone Marrow Transplantation Unit, Bahcelievler Medical Park Hospital, Altinbas University, Istanbul, Turkey.; Department of Pediatrics, Faculty of Medicine, Istinye University, Istanbul, Turkey.
Aydın MF; Department of Pediatrics, Faculty of Medicine, Pediatric Bone Marrow Transplantation Unit, Bahcelievler Medical Park Hospital, Altinbas University, Istanbul, Turkey.
Cipe FE; Department of Pediatrics, Faculty of Medicine, Pediatric Bone Marrow Transplantation Unit, Bahcelievler Medical Park Hospital, Altinbas University, Istanbul, Turkey.
Bozkurt C; Department of Pediatrics, Faculty of Medicine, Pediatric Bone Marrow Transplantation Unit, Bahcelievler Medical Park Hospital, Altinbas University, Istanbul, Turkey.; Department of Pediatrics, Faculty of Medicine, Istinye University, Istanbul, Turkey.
Fisgin T; Department of Pediatrics, Faculty of Medicine, Pediatric Bone Marrow Transplantation Unit, Bahcelievler Medical Park Hospital, Altinbas University, Istanbul, Turkey.; Pokaż więcej
Źródło:: Hemoglobin [Hemoglobin] 2021 Jan; Vol. 45 (1), pp. 25-29. Date of Electronic Publication: 2021 Jan 21.
Typ publikacji:: Journal Article
MeSH Terms:: Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
beta-Thalassemia*/therapy
Family ; Fetal Blood ; Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Allogeneic human umbilical cord Wharton's jelly stem cells increase several-fold the expansion of human cord blood CD34+ cells both in vitro and in vivo.
Autorzy:: Lin HD; Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Kent Ridge, 119228, Singapore.
Fong CY; Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Kent Ridge, 119228, Singapore.
Biswas A; Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Kent Ridge, 119228, Singapore.
Bongso A; Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Kent Ridge, 119228, Singapore. .; Pokaż więcej
Źródło:: Stem cell research & therapy [Stem Cell Res Ther] 2020 Dec 09; Vol. 11 (1), pp. 527. Date of Electronic Publication: 2020 Dec 09.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Mesenchymal Stem Cells*
Wharton Jelly*
Animals ; Antigens, CD34 ; Cells, Cultured ; Fetal Blood ; Humans ; Mice ; NADH Dehydrogenase ; Umbilical Cord

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: 830 nm photobiomodulation therapy promotes engraftment of human umbilical cord blood-derived hematopoietic stem cells.
Autorzy:: Yang J; Department of Dermatology, Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
Wang L; Department of Dermatology, Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
Wu MX; Department of Dermatology, Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2020 Nov 12; Vol. 10 (1), pp. 19671. Date of Electronic Publication: 2020 Nov 12.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:: Graft Survival*
Hematopoietic Stem Cell Transplantation*
Low-Level Light Therapy*
Fetal Blood/*cytology
Animals ; Humans ; Leukocyte Common Antigens ; Mice ; Mice, Inbred NOD ; Mice, SCID

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Meta-analysis of hematopoietic stem cell transplantation in major histocompatibility complex class II deficiency.
Autorzy:: Castano-Jaramillo LM; Facultad de Medicina, Universidad CES, Medellín, Colombia.
Bareño-Silva J; Facultad de Medicina, Universidad CES, Medellín, Colombia.
Tobon S; Department of Economics, Unversidad EAFIT, Medellín, Colombia.
Escobar-Gonzalez AF; Hospital Pablo Tobon Uribe, Medellín, Colombia.; Pokaż więcej
Źródło:: Pediatric transplantation [Pediatr Transplant] 2020 Sep; Vol. 24 (6), pp. e13774. Date of Electronic Publication: 2020 Jul 17.
Typ publikacji:: Journal Article; Meta-Analysis
MeSH Terms:: Hematopoietic Stem Cell Transplantation/*methods
Histocompatibility Antigens Class II/*immunology
Severe Combined Immunodeficiency/*therapy
Bone Marrow Transplantation ; Child, Preschool ; Fetal Blood ; Graft vs Host Disease ; Histocompatibility Testing ; Humans ; Infant ; Lymphocytes/cytology ; Prognosis ; Severe Combined Immunodeficiency/immunology ; Transplantation Conditioning ; Transplantation, Homologous/adverse effects ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Impact of osteoblast maturation on their paracrine growth enhancing activity on cord blood progenitors.
Autorzy:: Alsheikh M; Canadian Blood Services, Centre for Innovation, Ottawa, ON, Canada.; Biochemistry, Microbiology and Immunology Department, University of Ottawa, Ottawa, ON, Canada.
Abu-Khader A; Canadian Blood Services, Centre for Innovation, Ottawa, ON, Canada.
Michalicka M; Canadian Blood Services, Centre for Innovation, Ottawa, ON, Canada.; Biochemistry, Microbiology and Immunology Department, University of Ottawa, Ottawa, ON, Canada.
Pasha R; Canadian Blood Services, Centre for Innovation, Ottawa, ON, Canada.
Pineault N; Canadian Blood Services, Centre for Innovation, Ottawa, ON, Canada.; Biochemistry, Microbiology and Immunology Department, University of Ottawa, Ottawa, ON, Canada.; Pokaż więcej
Źródło:: European journal of haematology [Eur J Haematol] 2017 Jun; Vol. 98 (6), pp. 542-552. Date of Electronic Publication: 2017 Apr 21.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Cell Differentiation/*genetics
Fetal Blood/*metabolism
Hematopoietic Stem Cells/*metabolism
Osteoblasts/*metabolism
Paracrine Communication/*genetics
Adaptor Proteins, Signal Transducing ; Angiopoietin-Like Protein 1 ; Angiopoietin-like Proteins/genetics ; Angiopoietin-like Proteins/metabolism ; Animals ; Antigens, CD34/genetics ; Antigens, CD34/metabolism ; Calcium-Binding Proteins ; Culture Media, Conditioned/pharmacology ; Fetal Blood/cytology ; Fetal Blood/drug effects ; Gene Expression Regulation ; Hematopoietic Stem Cells/cytology ; Hematopoietic Stem Cells/drug effects ; Humans ; Insulin-Like Growth Factor Binding Protein 2/genetics ; Insulin-Like Growth Factor Binding Protein 2/metabolism ; Intercellular Signaling Peptides and Proteins/genetics ; Intercellular Signaling Peptides and Proteins/metabolism ; Membrane Proteins/genetics ; Membrane Proteins/metabolism ; Mesenchymal Stem Cells/cytology ; Mesenchymal Stem Cells/metabolism ; Mice ; Mice, Inbred NOD ; Osteoblasts/cytology ; Primary Cell Culture ; Receptors, Notch/genetics ; Receptors, Notch/metabolism ; Signal Transduction ; Transplantation, Heterologous ; Whole-Body Irradiation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Combining haplo-identical and cord blood stem cell grafts - might the whole be greater than the sum of its parts?
Autorzy:: Orfali N; Department of Bone Marrow Transplantation, Weill Cornell Medicine, New York, NY, USA.
van Besien K; Department of Bone Marrow Transplantation, Weill Cornell Medicine, New York, NY, USA.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2020 Apr; Vol. 61 (4), pp. 753-756. Date of Electronic Publication: 2020 Feb 12.
Typ publikacji:: Journal Article; Comment
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Unrelated Donors*
Fetal Blood ; Humans ; Neoplasm Recurrence, Local ; Transplantation Conditioning

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Comparison of outcomes of haploidentical donor hematopoietic stem cell transplantation supported by third-party cord blood with HLA-matched unrelated donor transplantation.
Autorzy:: Lyu H; Department of Hematology, Tianjin First Center Hospital, Tianjin, PR China.
Lu W; Department of Hematology, Tianjin First Center Hospital, Tianjin, PR China.
Yao J; Hematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Tianjin, PR China.
Xiao X; Department of Hematology, Tianjin First Center Hospital, Tianjin, PR China.
Li Q; Department of Hematology, Tianjin First Center Hospital, Tianjin, PR China.
Wang J; Department of Hematology, Tianjin First Center Hospital, Tianjin, PR China.
Mu J; Department of Hematology, Tianjin First Center Hospital, Tianjin, PR China.
Qi Y; Department of Hematology, Tianjin First Center Hospital, Tianjin, PR China.
Zhu H; Department of Hematology, Tianjin First Center Hospital, Tianjin, PR China.
Jiang Y; Department of Hematology, Tianjin First Center Hospital, Tianjin, PR China.
Li X; Department of Hematology, Tianjin First Center Hospital, Tianjin, PR China.
Meng J; Department of Hematology, Tianjin First Center Hospital, Tianjin, PR China.
Yuan T; Department of Hematology, Tianjin First Center Hospital, Tianjin, PR China.
He X; Department of Hematology, Tianjin First Center Hospital, Tianjin, PR China.
Jiang E; Hematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Tianjin, PR China.
Han M; Hematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Tianjin, PR China.
Zhao M; Department of Hematology, Tianjin First Center Hospital, Tianjin, PR China.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2020 Apr; Vol. 61 (4), pp. 840-847. Date of Electronic Publication: 2019 Nov 28.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Cord Blood Stem Cell Transplantation*/adverse effects
Graft vs Host Disease*/epidemiology
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Hematopoietic Stem Cell Transplantation*/adverse effects
Fetal Blood ; Humans ; Neoplasm Recurrence, Local ; Retrospective Studies ; Transplantation Conditioning ; Transplantation, Homologous ; Unrelated Donors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Human cord blood (hCB)-CD34+ humanized mice fail to reject human acute myeloid leukemia cells.
Autorzy:: Tanaskovic O; Department of Experimental Oncology at the IEO, European Institute of Oncology IRCCS, Milan, Italy.
Verga Falzacappa MV; Department of Experimental Oncology at the IEO, European Institute of Oncology IRCCS, Milan, Italy.
Pelicci PG; Department of Experimental Oncology at the IEO, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2019 Sep 19; Vol. 14 (9), pp. e0217345. Date of Electronic Publication: 2019 Sep 19 (Print Publication: 2019).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hematopoietic Stem Cell Transplantation*/methods
Fetal Blood/*cytology
Graft vs Leukemia Effect/*immunology
Hematopoietic Stem Cells/*metabolism
Leukemia, Myeloid, Acute/*immunology
Animals ; Antigens, CD34/metabolism ; Disease Models, Animal ; Humans ; Leukemia, Myeloid, Acute/metabolism ; Leukemia, Myeloid, Acute/therapy ; Mice ; Mice, Inbred NOD ; Mice, SCID

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Successful hematopoietic stem cell transplantation from an HLA-mismatched parent for engraftment failure after unrelated cord blood transplantation in patients with juvenile myelomonocytic leukemia: Report of two cases.
Autorzy:: Akahane K; Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
Watanabe A; Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
Furuichi Y; Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
Somazu S; Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
Oshiro H; Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
Goi K; Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
Sakashita K; Department of Hematology and Oncology, Nagano Children's Hospital, Nagano, Japan.
Muramatsu H; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Hama A; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Takahashi Y; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Koike K; Department of Pediatrics, Shinonoi General Hospital, Minami Nagano Center, Nagano, Japan.
Kojima S; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Sugita K; Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
Inukai T; Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.; Pokaż więcej
Źródło:: Pediatric transplantation [Pediatr Transplant] 2019 May; Vol. 23 (3), pp. e13378. Date of Electronic Publication: 2019 Feb 20.
Typ publikacji:: Case Reports
MeSH Terms:: Cord Blood Stem Cell Transplantation/*methods
HLA Antigens/*immunology
Hematopoietic Stem Cell Transplantation/*methods
Hematopoietic Stem Cells/*cytology
Leukemia, Myelomonocytic, Juvenile/*therapy
Child, Preschool ; Female ; Fetal Blood ; Hepatomegaly/surgery ; Humans ; Immunosuppressive Agents/therapeutic use ; Infant ; Male ; Mutation ; Recurrence ; Splenomegaly/surgery ; Transplantation Conditioning ; Treatment Outcome

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Adult T-cell leukemia/lymphoma in donor cells responding to second allogeneic hematopoietic stem cell transplantation using unrelated cord blood: the Nagasaki Transplant Group experience.
Autorzy:: Itonaga H; a Department of Hematology , Sasebo City General Hospital , Sasebo City , Nagasaki , Japan.; b Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit , Atomic Bomb Disease Institute, Nagasaki University , Nagasaki City , Nagasaki , Japan.
Taguchi J; b Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit , Atomic Bomb Disease Institute, Nagasaki University , Nagasaki City , Nagasaki , Japan.
Taguchi M; a Department of Hematology , Sasebo City General Hospital , Sasebo City , Nagasaki , Japan.
Taniguchi H; a Department of Hematology , Sasebo City General Hospital , Sasebo City , Nagasaki , Japan.
Sato S; a Department of Hematology , Sasebo City General Hospital , Sasebo City , Nagasaki , Japan.
Sawayama Y; b Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit , Atomic Bomb Disease Institute, Nagasaki University , Nagasaki City , Nagasaki , Japan.
Imaizumi Y; b Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit , Atomic Bomb Disease Institute, Nagasaki University , Nagasaki City , Nagasaki , Japan.
Yoshida S; c Department of Internal Medicine , National Hospital Organization Nagasaki Medical Center , Ohmura , Japan.
Hata T; b Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit , Atomic Bomb Disease Institute, Nagasaki University , Nagasaki City , Nagasaki , Japan.
Moriuchi Y; a Department of Hematology , Sasebo City General Hospital , Sasebo City , Nagasaki , Japan.
Miyazaki Y; b Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit , Atomic Bomb Disease Institute, Nagasaki University , Nagasaki City , Nagasaki , Japan.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2016 Dec; Vol. 57 (12), pp. 2946-2948. Date of Electronic Publication: 2016 May 23.
Typ publikacji:: Case Reports; Letter
MeSH Terms:: Cord Blood Stem Cell Transplantation*
Tissue Donors*
Fetal Blood/*physiology
Hematopoietic Stem Cell Transplantation/*adverse effects
Leukemia-Lymphoma, Adult T-Cell/*therapy
Adult ; Fetal Blood/transplantation ; Humans ; Iatrogenic Disease ; Leukemia-Lymphoma, Adult T-Cell/blood ; Male ; Remission Induction ; Transplantation, Homologous/adverse effects ; Unrelated Donors

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Fetal Blood"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język